Published on 23/12/2025

Global Regulatory Expectations for Zoonotic Assessments

Introduction to Zoonotic Risk Assessment in Veterinary Products

Zoonotic diseases, which are transmissible between animals and humans, culminate in significant public health issues as well as important economic consequences in animal health. The assessment of these zoonotic risks is essential in the regulatory submissions for veterinary products across major global markets, including the United States, the European Union, and the United Kingdom. As regulatory authorities like the FDA’s Center for Veterinary Medicine (CVM), European Medicines Agency (EMA), and the Medicines and Healthcare products Regulatory Agency (MHRA) continue to enhance their focus on zoonotic risks, a clear understanding of the regulatory framework is paramount for veterinary professionals involved in submissions.

This article presents a step-by-step guide on how to approach zoonotic risk assessments to align with the evolving regulatory requirements in the veterinary sector.

Step 1: Understand the Regulatory Framework

To effectively navigate the landscape of zoonotic risk assessments, it is essential to become familiar with the various guidelines and regulations established by different authorities. Below are some fundamental documents that should be reviewed:

• ICH Guidelines: The International Conference on Harmonisation provides recommendations related to the safety and efficacy of veterinary medicines.
• FDA Guidance Documents: Specific guidance regarding the assessment of zoonotic risks is critical. Notably, the FDA issues guidance on how to evaluate the potential human health risks of veterinary products.
• EMA Framework: The EMA has established guidelines focusing on the assessment of the potential zoonotic risks associated with veterinary medicinal products.
• MHRA Documentation: The UK’s regulatory authority also provides guidance and legal frameworks surrounding veterinary products, which include considerations for zoonotic potential.

Each of these documents lays the groundwork for understanding the underlying principles of zoonotic assessments. Regulatory professionals should emphasize adherence to these guidelines to ensure compliance in submissions.

Step 2: Identify Zoonoses Relevant to Your Product

Next, it is important to identify specific zoonotic pathogens relevant to the veterinary product under consideration. This can be achieved by analyzing existing scientific literature, epidemiological studies, and risk assessments. Key factors to consider include:

• Target Species: Determine which species are affected by the product and whether these species serve as carriers for zoonotic pathogens.
• Pathogen Profile: Assess the properties of potential zoonotic pathogens, including transmission routes, virulence, and prevalence.
• Pre-existing Knowledge: Utilize existing databases and resources to gather information on historical zoonotic occurrences related to similar products.

By systematically identifying relevant zoonoses, regulatory professionals can frame their risk assessment more effectively. This foundational work sets the stage for developing comprehensive assessments tailored to specific veterinary products.

Step 3: Conduct a Risk Assessment

The essence of a zoonotic risk assessment lies in the systematic evaluation of the likelihood of a zoonotic transmission occurring due to the product in question. The assessment typically includes the following components:

• Hazard Identification: For each potential pathogen identified earlier, assess its ability to cause disease in humans when transmitted from the target animal species.
• Exposure Assessment: Evaluate human exposure routes, considering factors such as handling, administering, or consuming products derived from the treated animals.
• Risk Characterization: Combine results of hazard identification and exposure assessment to characterize the risk, which will inform the necessary controls and mitigating actions.

In this stage, knowledge of both microbiological and epidemiological principles becomes crucial. Suitable methodologies such as the quantitative microbiological risk assessment ( QMRA) may be employed to ensure a rigorous evaluation.

Step 4: Implement Mitigation Strategies

Once potential risks have been characterized, the next step is to develop and implement strategies to mitigate these risks. Mitigation may include:

• Labeling Requirements: Clearly communicating risks on product labels to ensure users are informed.
• Animal Management Practices: Suggesting proper husbandry and health management practices to minimize disease spread.
• Monitoring Protocols: Establishing post-market surveillance systems to continuously monitor for zoonotic transmission evidence post-approval.

A collaborative approach with stakeholders, including veterinarians, farmers, and public health officials, can enhance the effectiveness of these mitigation strategies and foster compliance and awareness across the board.

Step 5: Document and Submit Your Findings

Preparing a comprehensive submission is the final step in articulating your zoonotic risk assessment to regulatory agencies. Elements of the submission should include:

• Executive Summary: A brief overview of the assessment outcomes, including identified risks and proposed mitigations.
• Risk Assessment Report: A detailed report encompassing hazard identification, exposure assessment, and risk characterization with references to supporting data.
• Mitigation Strategies Documentation: Include discussions on how risks will be managed and communicated.

Depending on the regulations from the EMA, FDA, and other agencies within the EU and UK, specific formatting or documentation may be required. Therefore, ensuring adherence to the relevant submission standards will be essential in expediting approval.

Step 6: Engage in Continuous Learning and Adjustments

The regulatory landscape for zoonotic risks is dynamic and subject to change. Veterinary professionals involved in regulatory submissions should engage in ongoing education through workshops, training programs, and staying updated with the latest scientific findings. Regular adjustments of the risk assessment based on new data or regulatory changes will reinforce the effectiveness of the provided documentations and the overall vetting process. Collaborating with regulatory consulting services specializing in zoonotic risk assessment can be beneficial to ensure compliance and leverage expert insights.

In conclusion, a robust zoonotic risk assessment is essential for veterinary product submissions in the current regulatory environment. By adhering to this structured approach, stakeholders can ensure that relevant pathogens are carefully evaluated against public health standards, thereby contributing to safer veterinary practices and protecting both animal and human health.